Get started
Author

Ma Luisa Suárez‐Gea

Observed names: M Luisa Suarez-Gea, M Luisa Suárez-Gea, M. L. SUAREZ‐GEA, M. L. Suarez-Gea, M. L. Suárez-Gea, M. Luisa Suarez-Gea, M. Luisa Suárez-Gea, M. Luisa Suárez‐Gea, M.L. Suárez-Gea, M.Luisa Suárez-Gea, M.M. Luisa Sua´rez-Gea, Ma Luisa Suárez-Gea, Ma.L. SUÁREZ‐GEA, Mª L. Suarez-Gea, Mª Luisa Suárez-Gea, Mª Luisa Suárez‐Gea, Mª Suárez-Gea
OpenAlex ID: A5110558220
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
2012 · A. Gomez-Outes, A. I. Terleira-Fernandez, et al. · BMJ · 260
PDF
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
2013 · Antonio Gómez-Outes, Ana Isabel Terleira-Fernández, et al. · Thrombosis · 184
PDF
Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
2021 · Antonio Gómez-Outes, Pau Alcubilla, et al. · Journal of the American College of Cardiology · 164
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
2014 · Antonio Gómez-Outes, Ana Isabel Terleira-Fernández, et al. · Thrombosis Research · 133
Discovery of Anticoagulant Drugs: A Historical Perspective
2012 · Antonio Gomez-Outes, M Luisa Suarez-Gea, et al. · Current Drug Discovery Technologies · 119
Direct‐acting oral anticoagulants: pharmacology, indications, management, and future perspectives
2015 · Antonio Gómez‐Outes, Mª Luisa Suárez‐Gea, et al. · European Journal Of Haematology · 91
Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism
2015 · Antonio Gómez-Outes, Ramón Lecumberri, et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 56
Specific Antidotes in Development for Reversal of Novel Anticoagulants: A Review
2015 · Antonio Gomez-Outes, Mª L. Suarez-Gea, et al. · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · 53
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
2014 · Antonio Gomez-Outes, M. Luisa Suarez-Gea, et al. · Vascular Health and Risk Management · 37
PDF
Discovery methods of coagulation-inhibiting drugs
2017 · Antonio Gómez-Outes, Minerva García-Fuentes, et al. · Expert Opinion on Drug Discovery · 26
Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison
2012 · Marta Herranz, Susana Morales-Alcelay, et al. · European Journal of Clinical Pharmacology · 25
Studies on the synthesis of cyanomethyleneamino pseudopeptides
1993 · Rosario Herranz, M. Luisa Suarez-Gea, et al. · The Journal of Organic Chemistry · 23
Synthesis of Ψ[CH(CN)NH] pseudopeptides. A new peptide bond surrogate
1991 · Rosario Herranz, M.Luisa Suárez-Gea, et al. · Tetrahedron Letters · 19
Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta‐analysis by geographic region with a focus on European patients
2016 · Antonio Gómez‐Outes, Ana‐Isabel Terleira‐Fernández, et al. · British Journal of Clinical Pharmacology · 18
Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate
1997 · Susana Herrero, M.Luisa Suárez-Gea, et al. · Bioorganic & Medicinal Chemistry Letters · 17
Ketomethylene and (Cyanomethylene)amino Pseudopeptide Analogs of the C-Terminal Hexapeptide of Neurotensin
1995 · Rosario Gonzalez-Muniz, M. Teresa Garcia-Lopez, et al. · Journal of Medicinal Chemistry · 17
Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products
2011 · Alfredo García-Arieta, Susana Morales-Alcelay, et al. · International Journal of Pharmaceutics · 16
Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis
2018 · Ana Terleira-Fernández, Ramón Lecumberri, et al. · Seminars in Thrombosis and Hemostasis · 15
Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions
2022 · Antonio Gómez-Outes, M Luisa Suárez-Gea, et al. · Expert Opinion on Pharmacotherapy · 10
Branched peptides and conformationally constrained analogues from cyanomethyleneamino pseudopeptides
1996 · M. Luisa Suárez-Gea, M. Teresa García-López, et al. · Tetrahedron Letters · 10
Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
2009 · A. GÓMEZ‐OUTES, Ma.L. SUÁREZ‐GEA, et al. · Journal of Thrombosis and Haemostasis · 7
PDF
Rivaroxaban versus enoxaparin after total knee arthroplasty
2009 · Antonio Gómez-Outes, M Luisa Suárez-Gea, et al. · The Lancet · 7
C-Backbone branched peptides via reductive amination of cyanomethyleneamino pseudopeptides
2002 · Susana Herrero, M.Luisa Suárez-Gea, et al. · Tetrahedron Letters · 7
A General Method for the Synthesis of Carbamoylmethyleneamino Pseudopeptides
1994 · M. Luisa Suarez-Gea, M. Teresa Garcia Lopez, et al. · The Journal of Organic Chemistry · 6
When and How to Use Reversal Agents for Direct Oral Anticoagulants?
2023 · Antonio Gómez-Outes, Mª Luisa Suárez-Gea, et al. · Current Cardiology Reports · 5
Works count: 34
Citation count: 1,334
H-index: 16
I10-index: 20
Year
Topic
Type